Cleveland biolabs Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Cleveland biolabs Contact Number

Cleveland BioLabs Crunchbase Company Profile & Funding

7 hours ago Crunchbase.com Show details

Phone Number 7168496820. Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications, with a focus on oncology and tissue protection. The company pursues the research, development, and commercialization of proprietary products that have the potential to treat cancer, prevent

Founded: Jul 01, 2007
Location: Buffalo, New York

Category: Contact NumberShow more

About Us Cleveland Bio Labs

Just Now Cbiolabs.org Show details

716-849-6810

Headquarters: Cleveland BioLabs, Inc. 73 High Street Buffalo, NY 14203 Tel: 716-849-6810 Fax: 716-849-6820 View Map

Category: Contact NumberShow more

Cleveland Biolabs Inc Cleveland ☎ 44106 11000 Cedar Ave

7 hours ago Local-health.net Show details

September 15, 2021 Cleveland Biolabs Inc in Cleveland 44106 listed as healthcare provider and we are located at the address 11000 Cedar Ave Ohio 44106 in Cleveland and you can contact us via email or phone, click here to learn more and get hours, ratings and healthcare advice from Cleveland Biolabs Inc and health experts in Cleveland and nearby.

Category: Contact NumberShow more

CBL0137 Cleveland Bio Labs

2 hours ago Cbiolabs.org Show details

716-849-6810

Headquarters: Cleveland BioLabs, Inc. 73 High Street Buffalo, NY 14203 Tel: 716-849-6810 Fax: 716-849-6820 View Map

Category: Contact NumberShow more

Cleveland Biolabs, Inc. in Seattle, WA Company Info

5 hours ago Bizapedia.com Show details

(716) 849-6810

Cleveland Biolabs, Inc. is a Washington Foreign Profit Corporation filed On August 6, 2020. The company's filing status is listed as Active and its File Number is 603056645. The Registered Agent on file for this company is Langdon L Miller MD and is located at 3057 Perkins Ln W, Seattle, WA 98199.

Founded: Aug 06, 2020
Phone: (716) 849-6810
Location: 73 High St, Buffalo, 14203-1149, NY

Category: Contact NumberShow more

Cleveland Biolabs, Inc. AnnualReports.com

9 hours ago Annualreports.com Show details

Cleveland Biolabs, Inc. Cleveland BioLabs, Inc. is a biotechnology focused on developing biodefense, tissue protection and cancer treatment drugs based on concept of modulation of cell death for therapeutic benefit. CBLI's pipeline includes products from two primary families of compounds: protectans and curaxins.

Category: Contact NumberShow more

Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to

9 hours ago Finance.yahoo.com Show details

Cleveland BioLabs, Inc. (NASDAQ: CBLI), an innovative biopharmaceutical company developing novel approaches to activate the immune system, today announced that the Company and Cytocom Inc., a

Category: Contact NumberShow more

Cleveland BioLabs, Inc. Investigation Weiss Law LLP

4 hours ago Weisslaw.co Show details

Cleveland BioLabs, Inc. Investigation. We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cleveland BioLabs, Inc. (“CBLI” or the “Company”) (NASDAQ: CBLI) in connection with the proposed merger of the Company with privately-held biopharmaceutical company, Cytocom, Inc

Category: Contact NumberShow more

CLEVELAND BIOLABS INC (Form: S4, Received: 02/16/2021 06

6 hours ago Content.edgar-online.com Show details

The amount of Cleveland BioLabs common stock to be registered is based on the estimated number of shares of Cleveland BioLabs common stock that are expected to be issued pursuant to the merger, assuming a maximum issuance of a number of shares equal to 66% of the total post-closing number of shares of Cleveland BioLabs to the holders of Cytocom

Category: Contact NumberShow more

Is Cleveland BioLabs Inc. (NASDAQ:CBLI) still hot stock

5 hours ago Baxterreport.com Show details

Cleveland BioLabs Inc. (CBLI) saw an uptrend of 8.73% in the recent trading with $4.98 being its most recent. The current price level -54.61% lower than the highest price of $10.97 marked by the stock while trading over the past 52-weeks, whereas it is 207.41% higher than the lowest price of $1.62 the company dropped to over past 52-weeks.

Category: Contact NumberShow more

Panacela Labs Crunchbase Company Profile & Funding

3 hours ago Crunchbase.com Show details

Contact Email [email protected]panacelalabs.com Phone Number (716)849-6810 Panacela Labs, Inc. is a joint venture company founded in 2011 by Cleveland BioLabs (Nasdaq:CBLI), a clinical-stage biotechnology company with a focus on oncology and orphan drug development, and Open Joint Stock Company “RUSNANO”, the largest Russian investment company, in

Category: Contact NumberShow more

Cleveland BioLabs, Inc. Announces Closing of $14 Million

5 hours ago Finance.yahoo.com Show details

(716) 849-6810

Contact: Cleveland BioLabs, Inc. (716) 849-6810 ext. 101 [email protected] At the same time, despite the increasing number of cases in this COVID wave, we’re not seeing a jump

Category: Contact NumberShow more

EX10.1

4 hours ago Sec.gov Show details

716-849-6810

Cleveland BioLabs, Inc. 73 High Street . Buffalo, New York USA 14203 . Attention: Chief Executive Officer . Facsimile: +1-716-849-6810 . Email: [email protected] With a copy (which shall not constitute notice) to: Cooley LLP . 500 …

Category: Contact NumberShow more

CLEVELAND BIOLABS INC (Form: 424B3, Received: 06/10/2021

9 hours ago Content.edgar-online.com Show details

Cleveland BioLabs, Inc., a Delaware corporation, or Cleveland BioLabs, and Cytocom Inc., a Delaware corporation, or Cytocom, entered into an Agreement and Plan of Merger, or the Merger Agreement, on October 16, 2020, pursuant to which High Street Acquisition Corp., a direct, wholly owned subsidiary of Cleveland BioLabs, or Merger Sub, will merge with and into Cytocom, …

Category: Contact NumberShow more

CBLI Stock Cleveland Biolabs Inc SEC Filings

Just Now Sec.report Show details

Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in the mitigation of radiation injury and immuno-oncology. Its lead product candidate is entolimod, an

Category: Contact NumberShow more

Cleveland Biolabs Inc (CBLI) 10K Annual Reports & 10Q SEC

6 hours ago Last10k.com Show details

The following information was filed by Cleveland Biolabs Inc (CBLI) on Friday, February 19, 2021 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in

Category: Contact NumberShow more

CBLI News Today (Cleveland BioLabs) MarketBeat

1 hours ago Marketbeat.com Show details

CLEVELAND BIOLABS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cleveland BioLabs, Inc. - CBLI finance.yahoo.com - October 26 at 5:19 PM Moore Kuehn Encourages CBLI, CEIX, PNM, and GLIBA Investors to Contact Law Firm

Category: Contact NumberShow more

Jim Mendolera Director of I.T. Cytocom, Inc. LinkedIn

Just Now Linkedin.com Show details

Cleveland Biolabs Apr 2007 - Jan 2016 8 Contact Jim directly by just using mobile number which is set as their URL.

Title: I.T. Director at Cytocom Inc, …
Location: East Aurora, New York, United States
Connections: 5

Category: Contact NumberShow more

Cytocom and Cleveland BioLabs Announce Definitive Merger

Just Now Accesswire.com Show details

646-558-8656

Cytocom will host a conference call and live audio webcast at 8:00 a.m. EDT on October 28 th to discuss the merger and provide a strategic vision for the combined company. To access the conference call supported with slides, please dial 646-558-8656 with the meeting ID: 841 7826 2704 and passcode: 281020.

Category: Contact NumberShow more

Cleveland BioLabs, Inc. and Cytocom Announce Registration

Just Now Prnewswire.com Show details

FORT COLLINS, Colo. and BUFFALO, N.Y., June 17, 2021 /PRNewswire/ -- Cleveland BioLabs, Inc. (NASDAQ: CBLI), an innovative biopharmaceutical company developing novel approaches to activate the

Category: Contact NumberShow more

Development of new inhibitors of androgen receptors SBIR.gov

5 hours ago Sbir.gov Show details

(773) 517-7282

Business Contact. Phone: (773) 517-7282. Research Institution. N/A The Cleveland Clinic Foundation (CCF) and Cleveland BioLabs, Inc. (CBL). Expertise in medicinal chemistry and lead optimization capabilities are provided by ChemBridge Corporation, a leading manufacturer of chemical libraries.

Category: Contact NumberShow more

Cleveland BioLabs Stock target price prediction (NCM:CBLI

6 hours ago Macroaxis.com Show details

The number of cover stories for Cleveland BioLabs depends on current market conditions and Cleveland BioLabs' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cleveland BioLabs is classified under.

Category: Contact NumberShow more

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces

4 hours ago Globenewswire.com Show details

WILMINGTON, Del., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Cleveland BioLabs, Inc. (“Cleveland”) (NASDAQ GS: CBLI) regarding possible

Category: Contact NumberShow more

Cleveland Biolabs Inc. Announces New Patents Strengthening

1 hours ago Biospace.com Show details

(917) 375-2935

Contact: Rachel Levine Vice President, Investor Relations Cleveland BioLabs, Inc. T: (917) 375-2935 E: [email protected]

Category: Contact NumberShow more

Cleveland BioLabs, Inc. (CBLI): What is good about stock

3 hours ago Marketingsentinel.com Show details

Cleveland BioLabs, Inc. (NASDAQ:CBLI)’s Major holders. Insiders own 50.26% of the company shares, while shares held by institutions stand at 6.67% with a share float percentage of 13.41%. Investors are also buoyed by the number of investors in a company, with Cleveland BioLabs, Inc. having a total of 22 institutions that hold shares in the

Category: Contact NumberShow more

Cleveland BioLabs, Inc. (Nasdaq CBLI) Brodsky Smith

9 hours ago Brodskysmith.com Show details

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Cleveland BioLabs, Inc. (Nasdaq – CBLI) BALA CYNWYD – October 19, 2020 /Access Wire/ – Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cleveland BioLabs, Inc. (“Cleveland BioLabs” or the “Company”) (Nasdaq – […]

Category: Contact NumberShow more

New class of biological radioprotectors SBIR.gov

5 hours ago Sbir.gov Show details

(773) 517-7282

Name: Yakov Kogan Title: Business Official Phone: (773) 517-7282 Email: [email protected]

Category: Contact NumberShow more

How Have the Numbers Shaped Up for Cleveland BioLabs

4 hours ago Stockmarketdaily.co Show details

Cleveland BioLabs, Inc. is estimated to report earnings on 06/11/2021. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date.

Category: Contact NumberShow more

Glenn Hart Vice President of Finance and Administration

8 hours ago Linkedin.com Show details

Vice President, Finance & Corporate Controller. Cleveland Biolabs. 2013 - 20141 year. Buffalo/Niagara, New York Area.

Title: Vice President of Finance and …
Location: Buffalo, New York, United States
Connections: 431

Category: Contact NumberShow more

Cleveland BioLabs Valuation Today CBLI Macroaxis

8 hours ago Macroaxis.com Show details

Cleveland BioLabs shows a prevailing Real Value of $3.52 per share. The current price of the firm is $3.78. At this time, the firm appears to be overvalued.Our model approximates the value of Cleveland BioLabs from analyzing the firm fundamentals such as return on equity of (31.86) %, and Current Valuation of 66.46 M as well as examining its technical indicators and Probability …

Category: Contact NumberShow more

Cbli20210706_8k.htm

6 hours ago Sec.gov Show details

(888) 613-8802

(Commission File Number) (I.R.S. Employer Identification Number) 2537 Research Boulevard, Suite 201. Fort Collins, CO 80526 (Address of Principal Executive Offices and zip code) (888) 613-8802 (Registrant's Telephone Number, Including Area Code) Cleveland BioLabs, Inc., 73 High Street, Buffalo, NY 14203

Category: Contact NumberShow more

Cleveland BioLabs, Inc. Announces Closing of $14 Million

7 hours ago Apnews.com Show details

Cleveland BioLabs, Inc. Announces Closing of $14 Million Registered Direct Offering of Common Stock February 23, 2021 GMT BUFFALO, NY / ACCESSWIRE / February 23, 2021 / Cleveland BioLabs, Inc. (NASDAQ:CBLI), today announced that it has closed its previously announced registered direct offering for the issuance and sale of 2,000,000 shares of

Category: Contact NumberShow more

Cleveland BioLabs Inc. (CBLI) Just Got Our Attention

4 hours ago Newsheater.com Show details

Cleveland BioLabs Inc. (NASDAQ:CBLI) went up by 16.96% from its latest closing price compared to the recent 1-year high of $10.97. The company’s stock price has collected 7.59% of gains in the last five trading sessions. Press Release reported 1 hour ago that Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting …

Category: Contact NumberShow more

SHAREHOLDER ALERT: Barr Law Group Investigating ZM, CBLI

1 hours ago Ca.finance.yahoo.com Show details

(619) 400-4966

SAN DIEGO, Nov. 10, 2020 (GLOBE NEWSWIRE) -- National law firm Barr Law Group is investigating Zoom Video Communications, Inc., Cleveland BioLabs, Inc., BioSpecifics Technologies Corp., and Restaurant Brands International. Shareholders are encouraged to contact [email protected] or call (619) 400-4966. Zoom Video Communications, Inc. …

Category: Contact NumberShow more

STAB Stock Message Board Statera Biopharma, Inc

2 hours ago Investorshangout.com Show details

STAB Stock Message Board for Investors. Statera Biopharma, Inc. Stock Price, News and Company Updates. Message Board Total Posts: 36

Category: Contact NumberShow more

Hello, Cleveland Biolabs! Here comes a merger with Cytocom

2 hours ago Cytocom.com Show details

Privately held Cytocom Inc. and Cleveland Biolabs Inc. will merge in an all-stock transaction, with Cytocom shareholders taking the majority position. The transaction, which must be approved by Cleveland Biolabs’ shareholders, is expected to close in the first quarter of 2021.

Category: Contact NumberShow more

Cleveland BioLabs, Inc. Announces $14 Million Registered

1 hours ago Birminghamnews.net Show details

BUFFALO, NY / ACCESSWIRE / February 19, 2021 / Cleveland BioLabs, Inc. (NASDAQ:CBLI), today announced that it has entered into definitive agreements with certain healthcare-focused and institutional investors for the issuance and sale of 2,000,000 shares of its common stock at a purchase price of $7.00 per share in a registered direct offering.The …

Category: Contact NumberShow more

Immune Therapeutics, Inc. Announces Signing of Definitive

2 hours ago Globenewswire.com Show details

Security holders may obtain information regarding the names, affiliations and interests of Cleveland BioLabs’ directors and officers in Cleveland BioLabs’ Annual Report on Form 10-K for the

Category: Contact NumberShow more

Shareholders approve CytocomCleveland BioPharma merger

7 hours ago Bizwest.com Show details

FORT COLLINS — A proposed merger between Fort Collins-headquartered pharmaceutical company Cytocom Inc. and Cleveland BioLabs Inc. (Nasdaq: CBLI) was approved this week by CBI shareholders and is expected to close in the coming days. Upon closure, the combined company — called Cytocom Inc. — will be traded on the Nasdaq …

Category: Contact NumberShow more

Statera BioPharma Inc – Indentures – BamSEC

5 hours ago Bamsec.com Show details

from 8-K 8 pages Warrant Number: H-1 Issue Date: September 3, 2013 Cleveland Biolabs, Inc. Warrant to Purchase Common Stock

Category: Contact NumberShow more

Cytocom, Inc. Reports Second Quarter 2021 Financial Results

3 hours ago Prnewswire.com Show details

-All-stock merger transaction between legacy Cleveland BioLabs and legacy Cytocom recently completed; Cytocom, Inc. common stock trading on Nasdaq as "CBLI"- Weighted average number of shares

Category: Contact NumberShow more

CLEVELAND BIOLABS INC : Completion of Acquisition or

6 hours ago Marketscreener.com Show details

Item 2.01 Completion of Acquisition or Disposition of Assets. The information provided in the Introductory Note of this Current Report on Form 8-K is incorporated herein by reference. Merger October 9, 2021

Category: Contact NumberShow more

Statera BioPharma, Inc. 10K Apr. 14, 2020 6:27 PM

9 hours ago Seekingalpha.com Show details

For the transition period from to . Commission file number 001-32954. CLEVELAND BIOLABS, INC. (Exact name of registrant as specified in its charter)

Category: Contact NumberShow more

Cytocom Inc. Provides Update on Completed Merger with

9 hours ago Centralcharts.com Show details

"With the Cleveland BioLabs merger completed and Cytocom now operating as a publicly-traded company, the management team at Cytocom is in the process of integrating both companies as we are rapidly advancing our late-stage clinical programs and expanding our toll-like receptor platforms," stated Michael K. Handley, President and CEO of Cytocom Inc.

Category: Contact NumberShow more

How to buy Cleveland BioLabs stock (NASDAQ: CBLI) stock

Just Now Finder.com Show details

However Cleveland BioLabs's short interest can also be evaluated against the total number of Cleveland BioLabs shares, or, against the total number of tradable Cleveland BioLabs shares (the shares that aren't held by "insiders" or major long-term shareholders – …

Category: Contact NumberShow more

BioLabs' shareholder questions ROI Buffalo Business First

9 hours ago Bizjournals.com Show details

The company’s chief financial officer, C. Neil Lyons, said Cleveland BioLabs and its subsidiaries have about $50 million in cash (that number includes investments and grant commitments), enough

Category: Contact NumberShow more

Genius Brands International, Inc. (GNUS) investors to reap

4 hours ago Marketingsentinel.com Show details

Genius Brands International, Inc. (NASDAQ:GNUS) has a beta value of 1.79 and has seen 5,343,386 shares traded in the last trading session. The company, currently valued at $523.38 Million, closed the last trade at $1.74 per share which meant it lost -$0.02 on the day or -1.14% during that session. T

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Popular Brands

Costco
Cisco
Ccu
Cae